Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

655 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome.
Forget MA, Haymaker C, Hess KR, Meng YJ, Creasy C, Karpinets T, Fulbright OJ, Roszik J, Woodman SE, Kim YU, Sakellariou-Thompson D, Bhatta A, Wahl A, Flores E, Thorsen ST, Tavera RJ, Ramachandran R, Gonzalez AM, Toth CL, Wardell S, Mansaray R, Patel V, Carpio DJ, Vaughn C, Farinas CM, Velasquez PG, Hwu WJ, Patel SP, Davies MA, Diab A, Glitza IC, Tawbi H, Wong MK, Cain S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Wargo JA, Radvanyi LG, Torres-Cabala CA, Beroukhim R, Hwu P, Amaria RN, Bernatchez C. Forget MA, et al. Among authors: gonzalez am. Clin Cancer Res. 2018 Sep 15;24(18):4416-4428. doi: 10.1158/1078-0432.CCR-17-3649. Epub 2018 May 30. Clin Cancer Res. 2018. PMID: 29848573 Free PMC article.
Utilizing T-cell Activation Signals 1, 2, and 3 for Tumor-infiltrating Lymphocytes (TIL) Expansion: The Advantage Over the Sole Use of Interleukin-2 in Cutaneous and Uveal Melanoma.
Tavera RJ, Forget MA, Kim YU, Sakellariou-Thompson D, Creasy CA, Bhatta A, Fulbright OJ, Ramachandran R, Thorsen ST, Flores E, Wahl A, Gonzalez AM, Toth C, Wardell S, Mansaray R, Radvanyi LG, Gombos DS, Patel SP, Hwu P, Amaria RN, Bernatchez C, Haymaker C. Tavera RJ, et al. Among authors: gonzalez am. J Immunother. 2018 Nov/Dec;41(9):399-405. doi: 10.1097/CJI.0000000000000230. J Immunother. 2018. PMID: 29757889 Free PMC article. Clinical Trial.
Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients.
Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G, Glass M, Johnson VE, McMannis JD, Shpall E, Prieto V, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Patel S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Davies MA, Mansaray R, Fulbright OJ, Toth C, Ramachandran R, Wardell S, Gonzalez A, Hwu P. Radvanyi LG, et al. Clin Cancer Res. 2012 Dec 15;18(24):6758-70. doi: 10.1158/1078-0432.CCR-12-1177. Epub 2012 Oct 2. Clin Cancer Res. 2012. PMID: 23032743 Free PMC article. Clinical Trial.
A Novel Method to Generate and Expand Clinical-Grade, Genetically Modified, Tumor-Infiltrating Lymphocytes.
Forget MA, Tavera RJ, Haymaker C, Ramachandran R, Malu S, Zhang M, Wardell S, Fulbright OJ, Toth CL, Gonzalez AM, Thorsen ST, Flores E, Wahl A, Peng W, Amaria RN, Hwu P, Bernatchez C. Forget MA, et al. Among authors: gonzalez am. Front Immunol. 2017 Aug 2;8:908. doi: 10.3389/fimmu.2017.00908. eCollection 2017. Front Immunol. 2017. PMID: 28824634 Free PMC article.
A Core Outcome Set for Trials in CKD: Report of the Standardized Outcomes in Nephrology-Chronic Kidney Disease (SONG-CKD) Stakeholder Workshops.
Gonzalez AM, Cazzolli R, Madero M, Evangelidis N, Howell M, Sautenet B, Bernier-Jean A, Cho Y, Sanabria LC, Craig JC, de Boer IH, Fung S, Gallego D, Guha C, Shen JI, Levey AS, Levin A, Lorca E, Cabrera S, Mellado H, Molina S, Atilano X, Sandino L, Arancibia M, Sepulveda A, Urra M, Bravo MLA, Manera K, Recabarren J, Okpechi IG, Rossignol P, Scholes-Robertson N, Sola L, Teixeira-Pinto A, Usherwood T, Viecelli AK, Wheeler DC, Widders K, Jaure A; SONG-CKD Stakeholder Workshop Investigators. Gonzalez AM, et al. Am J Kidney Dis. 2025 Jan 22:S0272-6386(25)00039-3. doi: 10.1053/j.ajkd.2024.10.013. Online ahead of print. Am J Kidney Dis. 2025. PMID: 39855535
REM obstructive sleep apnea: prevalence and clinical associations in a high-altitude population.
Severiche Bueno DF, Gonzalez AM, Rivera-Leon DP, Vargas Cuervo MT, Mateus-Palacios JM, Agudelo-Agudelo J, Casas DP, Enciso-B LF, Proaños NJ, Fernández-Bernal F, Dueñas Meza E, Gonzalez M, Bazurto Zapata MA. Severiche Bueno DF, et al. Among authors: gonzalez am. J Clin Sleep Med. 2025 Jan 13. doi: 10.5664/jcsm.11556. Online ahead of print. J Clin Sleep Med. 2025. PMID: 39797404
Multispecies emergence of dual blaKPC/NDM carbapenemase-producing Enterobacterales recovered from invasive infections in Chile.
Quesille-Villalobos AM, Solar C, Martínez JRW, Rivas L, Quiroz V, González AM, Riquelme-Neira R, Ugalde JA, Peters A, Ortega-Recalde O, Araos R, García P, Lebreton F, Munita JM, Diaz L. Quesille-Villalobos AM, et al. Among authors: gonzalez am. Antimicrob Agents Chemother. 2024 Dec 5:e0120524. doi: 10.1128/aac.01205-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 39636127 Free article.
655 results